OncoDNA announces ISO 27001 certification for information security management and storage
• Confirming OncoDNA’s high quality standard used for safe data handling and security
OncoDNA (“OncoDNA or “the Company”), the healthcare technology company making precision medicine a reality, announces having received ISO 27001 :2013 certification for information security management and storage.
ISO/IEC 27001:2013 is an international standard that outline the requirements for an optimal management of information security management systems. To achieve this certification, the company went under in-depth audit by a certification accredited body to demonstrate his ability to protect the privacy of customers’ data. Our backup and redundant servers stored in a secured datacentre were also audited to demonstrate our capacity to provide service continuity in any circumstance.
The certification of OncoDNA includes the entire IT infrastructure where the data is stored and processed for the provision of OncoDNA’s services as well as the support processes for the management of the ISMS (Management, Risk Management, Human Resources & Purchase).
Jean-Pol Detiffe, Chief Executive Officer of OncoDNA, said:
“This certification is an essential piece for the development of OncoDNA as well as the commercialization of our OncoKDM platform. This decision platform is turning cancer data into knowledge driven medicine. It enables lab directors and pathologists to import their raw molecular data directly into our platform. In no more than 1 or 2 days, OncoKDM will get back to the lab manager with a useful and comprehensive report that can be reviewed, validated and then transferred to the oncologist to support his patient treatment decision. With the ISO 27001 certification OncoDNA is confirming the very high quality and security standard used benefiting cancer care for the patient.”
The international standard ISO 27001 is awarded to a company for best practices for information security management systems. Compliance with these standards demonstrates OncoDNA commitment to a repeatable, continuously improving, risk-based security program. The management system was inspected by the International Certification Trust Services (Icts).
About OncoDNA :
OncoDNA is a private, oncology-focused healthcare technology company that combines advanced, comprehensive testing of all clinically relevant cancer biomarkers (DNA, RNA and protein profiles) from both solid and liquid biopsies with a proprietary cancer treatment knowledge database called OncoKDO that continuously ‘learns’ from cutting-edge, validated, scientific and medical advances. This one-stop-shop analysis and interpretation service gives oncologists actionable results to enable the selection of treatments tailored to an individual patient’s cancer profile. OncoDNA also works in collaboration with the biopharma industry to develop and deliver the treatments of tomorrow by assisting with design, enrolment and assessment of clinical trials as well as increasing access to approved precision medicines. The company is based in Gosselies, Belgium, and employs c.55 employees in four countries. For more information please visit www.oncodna.com
|OncoDNA||+32 (0) 71 18 35 00|
|Jean-Pol Detiffe, CEO|